Henry James International Management Inc. Has $4.99 Million Position in Smith & Nephew plc (NYSE:SNN)

Henry James International Management Inc. lowered its stake in shares of Smith & Nephew plc (NYSE:SNN) by 0.8% in the fourth quarter, Holdings Channel reports. The firm owned 183,076 shares of the medical equipment provider’s stock after selling 1,507 shares during the period. Smith & Nephew comprises about 1.9% of Henry James International Management Inc.’s holdings, making the stock its 15th biggest position. Henry James International Management Inc.’s holdings in Smith & Nephew were worth $4,994,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. American Century Companies Inc. boosted its holdings in shares of Smith & Nephew by 343.5% during the 3rd quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock worth $58,557,000 after buying an additional 1,830,965 shares during the period. Scharf Investments LLC increased its stake in shares of Smith & Nephew by 20.5% in the fourth quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock worth $81,304,000 after purchasing an additional 506,474 shares during the period. Hsbc Holdings PLC bought a new position in shares of Smith & Nephew in the third quarter worth about $8,174,000. Envestnet Asset Management Inc. lifted its position in shares of Smith & Nephew by 133.6% during the 3rd quarter. Envestnet Asset Management Inc. now owns 539,491 shares of the medical equipment provider’s stock worth $13,363,000 after purchasing an additional 308,559 shares during the last quarter. Finally, Clark Estates Inc. NY boosted its stake in Smith & Nephew by 83.3% during the 3rd quarter. Clark Estates Inc. NY now owns 550,000 shares of the medical equipment provider’s stock valued at $13,624,000 after purchasing an additional 250,000 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Stock Up 1.4 %

Shares of SNN traded up $0.34 during trading hours on Friday, reaching $24.78. 1,063,758 shares of the company traded hands, compared to its average volume of 1,109,205. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. The stock’s fifty day moving average is $25.57 and its 200 day moving average is $26.01. Smith & Nephew plc has a 1-year low of $21.52 and a 1-year high of $32.71.

Smith & Nephew Announces Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be issued a dividend of $0.462 per share. This represents a dividend yield of 2.8%. The ex-dividend date is Monday, April 1st.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.